A study to evaluate the concurrent cetuximab versus platinum-based chemoradiation in patients with locoregionally advanced head and neck cancer.
Phase of Trial: Phase IV
Latest Information Update: 11 Oct 2016
At a glance
- Drugs Cetuximab (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- Acronyms SOCCER
- 11 Oct 2016 Interim results from non-selected patient cohort presented at the 41st European Society for Medical Oncology Congress.
- 28 Sep 2016 According to the Merck and Co. media release, the company will present data of an interim analysis from non-selected patient cohort of this trial at the European Society for Medical Oncology (ESMO) annual meeting.
- 11 Feb 2016 New trial record